Skip to Main Content

Paper Details

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
2
2023
BC, BRCA1, BRCA1/2, BRCA1/2 mutations, ER, ER+, ER+BC, GIS, HRD, Ovarian cancer, TNBC, TNBC samples, TNBC tumors, breast cancer, estrogen, estrogen receptor, homologous recombination deficiency, ovarian cancer, patients, platinum, triple-negative breast cancer, tumors
Author NameAffiliation
Judy C BougheyMayo Clinic
Matthew P GoetzMayo Clinic
James M FordStanford University School of Medicine
Paul K MarcomDuke University
Andrea L RichardsonSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Anna Maria StornioloMelvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine
Zhongwu Lai
Gordon B MillsOregon Health & Science University
Gordon B MillsOregon Health & Science University
Vered StearnsSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
  • 1 - 10

Datasets

Release 1.2